The global automated cardiopulmonary resuscitation (CPR) device industry is set for steady growth, with an estimated valuation of USD 150.6 million in 2024, projected to expand to USD 255.7 million by 2034. This represents a compound annual growth rate (CAGR) of 5.4% over the assessment period, driven by increasing demand for advanced life-saving technologies.
The rising prevalence of cardiovascular diseases (CVD) globally has significantly heightened the demand for efficient and reliable resuscitation solutions. Deaths attributable to CVD have risen from 28.9% in 1990 to 36.3% in 2020, with 19.8 million fatalities reported in 2020 alone. Automated CPR devices offer consistent and effective chest compressions, addressing critical needs during cardiac emergencies and improving survival outcomes.
As healthcare systems worldwide prioritize innovations in emergency response, automated CPR devices are gaining traction in hospitals, ambulances, and public spaces. Their precision, ease of use, and ability to alleviate caregiver fatigue make them indispensable tools in high-stakes situations. This technological advancement aligns with global efforts to combat the growing burden of cardiovascular diseases.
Get Full Report Now – https://www.futuremarketinsights.com/reports/automated-cpr-devices-market
Key Takeaways:
- Market Growth: Valued at USD 150.6 million in 2024, projected to reach USD 255.7 million by 2034, with a CAGR of 5.4%.
- CVD Impact: Cardiovascular diseases remain the leading cause of death globally, accounting for 19.8 million deaths in 2020.
- Technology Focus: Automated CPR devices ensure consistent, high-quality chest compressions, addressing critical gaps in cardiac care.
- Expanding Adoption: Increasing use across healthcare facilities and emergency response units highlights the importance of automation in life-saving interventions.
For more insights on the automated CPR device market and its role in shaping the future of emergency healthcare, stay updated with our latest reports and analyses.
Factors Driving Market Growth
- Rising Incidence of Cardiovascular Disease (CVD): The prevalence of cardiovascular diseases has significantly increased, with global deaths from CVD rising from 28.9% in 1990 to 36.3% in 2020, leading to an urgent need for effective resuscitation solutions.
- Need for Efficient Emergency Response: With nearly 19.8 million deaths attributed to cardiovascular diseases in 2020, automated CPR devices provide a critical solution for emergency medical services (EMS) and hospitals to improve survival rates during cardiac arrest situations.
- Technological Advancements: Innovations in automated CPR devices enhance their effectiveness and ease of use, making them attractive options for healthcare providers.
- Increased Awareness and Training: Growing awareness of the importance of CPR and the benefits of automated devices in emergency situations is driving market demand.
- Government Initiatives and Funding: Supportive government policies and funding for emergency medical services are facilitating the adoption of automated CPR devices.
Regional Insights
- North America is expected to lead the market, driven by high adoption rates of advanced medical technologies and a significant burden of chronic diseases.
- The Asia-Pacific region is anticipated to experience substantial growth due to increasing awareness of heart disease management and technological advancements.
Competition Outlook
The mechanical CPR device market encompasses a diverse and dynamic competitive landscape. Leading automated CPR device manufacturing companies are focusing on new product launches and approvals to stay ahead of the competition.
Several companies are focusing on strengthening presence across regions with high chronic disease prevalence and aging populations. This is because these factors often increase chances of cardiac arrest.
Key players are also striving to increase the adoption of mechanical CPR devices by investing in awareness campaigns. Showcasing latest CPR device innovations at tradeshows and other exhibitions is also becoming a key strategy of companies.
Partnership and support from government agencies are also helping companies to boost sales. Many government agencies are offering grants for purchase of mechanical CPR devices.
There has also been an increased demand for CPR solutions from fire safety department, which has improved the uptake of mechanical CPR devices. Players are also deploying strategies such as mergers, distribution agreements, collaborations, and acquisitions to increase market reach.
Industry Updates
- In April 2023, the European Resuscitation Council (ERC) partnered with Sunlife Science, a leading China-based provider of CPR solutions, with the aim to improve the survival rate and outcomes of cardiac arrest patients.
- In April 2023, Nordic Capital acquired a high stake in Germany-based Corpuls, an innovative medical technology company specializing in emergency cardiac resuscitation and other medical solutions, to boost the company’s growth.
Leading Automated CPR Device Brands
- Stryker Corporation
- ZOLL Medical Corporation
- Corpuls
- Schiller AG
- Shenzhen Bangvo Technology Co., Ltd.
- Defibtech LLC
- SunLife Science
- Michigan Instruments
- Ambulanc (Shenzhen) Tech. Co. Ltd. (Amoul)
- Others
Key Segments of Market Report
By Product:
Based on product, the industry has been categorized into piston-based devices and load-distributing band-based devices.
By Modality:
In terms of modality, the market is categorized into battery-driven and electrically-driven.
By End-user:
Different end-users include hospitals (emergency departments, ICUs, and others), ambulatory medical centers, specialty clinics, emergency medical services (ambulances and air ambulances), independent catheterization labs, and long-term care centers.
By Region:
Industry analysis has been carried out in key countries of North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, and Middle East and Africa.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
